Cite
Additional file 5 of Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer
MLA
Kang, Ning, et al. Additional File 5 of Identification and Validation of EMT-Immune-Related Prognostic Biomarkers CDKN2A, CMTM8 and ILK in Colon Cancer. Jan. 2022. EBSCOhost, https://doi.org/10.6084/m9.figshare.19608160.v1.
APA
Kang, N., Xie, X., Zhou, X., Wang, Y., Chen, S., Qi, R., Liu, T., & Jiang, H. (2022). Additional file 5 of Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer. https://doi.org/10.6084/m9.figshare.19608160.v1
Chicago
Kang, Ning, Xiaoli Xie, Xue Zhou, Yijun Wang, Shengxiong Chen, Ran Qi, Ting Liu, and Huiqing Jiang. 2022. “Additional File 5 of Identification and Validation of EMT-Immune-Related Prognostic Biomarkers CDKN2A, CMTM8 and ILK in Colon Cancer,” January. doi:10.6084/m9.figshare.19608160.v1.